Van Hulzen Asset Management LLC Has $377,000 Stake in Tilray Inc (NASDAQ:TLRY)

Van Hulzen Asset Management LLC grew its stake in Tilray Inc (NASDAQ:TLRYGet Rating) by 40.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 48,583 shares of the company’s stock after purchasing an additional 14,106 shares during the period. Van Hulzen Asset Management LLC’s holdings in Tilray were worth $377,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Westside Investment Management Inc. lifted its holdings in shares of Tilray by 13.4% during the 1st quarter. Westside Investment Management Inc. now owns 17,800 shares of the company’s stock worth $13,588,000 after acquiring an additional 2,100 shares during the period. Arcus Capital Partners LLC lifted its holdings in Tilray by 22.0% during the 1st quarter. Arcus Capital Partners LLC now owns 12,687 shares of the company’s stock valued at $99,000 after purchasing an additional 2,287 shares during the last quarter. Wedbush Securities Inc. lifted its holdings in Tilray by 6.1% during the 1st quarter. Wedbush Securities Inc. now owns 42,706 shares of the company’s stock valued at $332,000 after purchasing an additional 2,453 shares during the last quarter. Toronto Dominion Bank lifted its holdings in Tilray by 57.1% during the 1st quarter. Toronto Dominion Bank now owns 7,692 shares of the company’s stock valued at $60,000 after purchasing an additional 2,795 shares during the last quarter. Finally, Private Advisor Group LLC lifted its holdings in Tilray by 7.9% during the 4th quarter. Private Advisor Group LLC now owns 41,350 shares of the company’s stock valued at $291,000 after purchasing an additional 3,027 shares during the last quarter. 12.10% of the stock is currently owned by institutional investors and hedge funds.

Tilray Trading Up 0.3 %

TLRY opened at $3.39 on Friday. The firm’s fifty day moving average is $3.65 and its two-hundred day moving average is $4.52. The firm has a market cap of $1.82 billion, a PE ratio of -3.81 and a beta of 2.51. Tilray Inc has a twelve month low of $3.00 and a twelve month high of $13.95. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.99 and a current ratio of 2.87.

Tilray (NASDAQ:TLRYGet Rating) last posted its earnings results on Thursday, July 28th. The company reported ($0.34) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.27). Tilray had a negative return on equity of 4.14% and a negative net margin of 71.52%. The business had revenue of $153.30 million for the quarter, compared to the consensus estimate of $151.53 million. During the same quarter in the prior year, the firm posted ($0.11) earnings per share. The business’s revenue was up 7.8% on a year-over-year basis. Equities research analysts anticipate that Tilray Inc will post -0.22 EPS for the current year.

Insider Activity at Tilray

In related news, Director Brendan Kennedy sold 350,000 shares of the stock in a transaction that occurred on Tuesday, September 6th. The stock was sold at an average price of $3.22, for a total transaction of $1,127,000.00. Following the completion of the sale, the director now directly owns 6,924,196 shares of the company’s stock, valued at approximately $22,295,911.12. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 3.17% of the stock is owned by insiders.

Analyst Ratings Changes

TLRY has been the subject of several analyst reports. Canaccord Genuity Group cut their price target on shares of Tilray from $9.00 to $7.00 in a report on Wednesday, June 15th. Cowen dropped their target price on shares of Tilray from $23.00 to $9.00 in a research note on Friday, July 29th. Cantor Fitzgerald dropped their target price on shares of Tilray from $5.75 to $4.15 and set a “neutral” rating for the company in a research note on Tuesday, August 2nd. Piper Sandler dropped their target price on shares of Tilray from $6.00 to $3.00 and set a “neutral” rating for the company in a research note on Wednesday, June 15th. Finally, Benchmark downgraded shares of Tilray from a “hold” rating to a “sell” rating and set a $3.00 target price for the company. in a research note on Friday, July 29th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, Tilray presently has a consensus rating of “Hold” and an average target price of $7.15.

Tilray Company Profile

(Get Rating)

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.

Featured Articles

Want to see what other hedge funds are holding TLRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tilray Inc (NASDAQ:TLRYGet Rating).

Institutional Ownership by Quarter for Tilray (NASDAQ:TLRY)

Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.